Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
146.00    2.00 (1.37%)
Bid:
142.00
Ask:
150.00
Spread: 8.00 (5.634%)
Market Cap: £45.71m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Trading Update - Improved Outlook

21 May 2021 07:00

RNS Number : 3603Z
Gattaca PLC
21 May 2021
 

21 May 2021

Gattaca plc

 

Trading Update - Improved Outlook

 

("Gattaca", the "Group" or "the Company")

 

Gattaca plc, the specialist Engineering and Technology recruitment solutions business, today issues a trading update for FY ending 31 July 2021.

 

Since we announced our half year results on 31 March we have seen a faster rate of recovery in NFI than originally expected. In Q3 we are pleased to have delivered quarter-on-quarter UK NFI growth of 13% across a broad range of segments. In addition, the changes arising from the introduction of new tax legislation (IR35) had less of an impact on the Company than we anticipated. We now expect NFI in H2 to be in the order of 10% up on H1 2021. We are continuing our successful recruitment drive and making targeted investment in sales and delivery headcount, whilst closely managing our cost base. Our Global technology platform, providing the Group with a fully integrated and flexible centralised system, was launched successfully in the U.K. during April.

 

Whilst there remains uncertainty around Covid-19, our current expectation is that this rate of recovery will continue, and we therefore expect our underlying continuing profit before tax for the year to 31 July 2021 will be significantly ahead of market expectations.

 

In light of the improved performance and assuming a continuation of the current positive trends, the Board anticipates the recommendation of a modest dividend when the full year results are announced.

 

Kevin Freeguard, CEO commented:

 

"We are pleased with our Q3 performance. Our people are capitalising on the opportunities to move us at pace as we grow beyond the pandemic. The strategy and focus on STEM skills and Contract staffing is serving us well and we are seeing improved underlying activity across our core markets, including Infrastructure and Defence."

 

For further information please contact:

 

Gattaca plc

+44 (0) 1489 898989

Kevin Freeguard, Chief Executive Officer

 

Salar Farzad, Chief Financial Officer

 

 

 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

 

Robert Morton

 

Euan Brown

 

 

 

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Toby Mountford

 

Jos Bieneman

 

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVDEEIIFIL
Date   Source Headline
9th Dec 20169:25 amRNSBlock Admission
8th Dec 201610:24 amRNSDirector/PDMR Shareholding
8th Dec 20167:00 amRNSResult of AGM
5th Dec 201612:08 pmRNSBLOCK LISTING SIX MONTHLY RETURN
25th Nov 20168:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Nov 20162:08 pmRNSNotice of AGM
3rd Nov 20167:00 amRNSPreliminary Results
26th Sep 20167:00 amRNSSite Visit
12th Sep 20167:00 amRNSChange of name and website
19th Aug 20167:00 amRNSProposal for Change of Name - Notice of EGM
11th Aug 20163:59 pmRNSDirector/PDMR Shareholding
4th Aug 20167:00 amRNSTrading Update for 12 months ended 31 July 2016
22nd Jul 20164:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 20162:05 pmRNSDirector / PDMR Shareholding
18th Jul 20167:00 amRNSMatchtech Group plc to become Gattaca plc
7th Jul 20167:00 amRNSDirector/PDMR Shareholding
6th Jun 20162:59 pmRNSBlock Listing Six Monthly Return
14th Apr 20167:00 amRNSInterim Results to 31 January 2016
18th Feb 20164:40 pmRNSSecond Price Monitoring Extn
18th Feb 20164:35 pmRNSPrice Monitoring Extension
15th Feb 20164:43 pmRNSDirector/PDMR Shareholding
12th Feb 20167:00 amRNSDirector/PDMR Shareholding
28th Jan 20167:00 amRNSTrading Update
27th Jan 20161:00 pmRNSDirector/PDMR Shareholding
19th Jan 20161:15 pmRNSCorrection - Director / PDMR Shareholding
18th Jan 20167:00 amRNSDirector/PDMR Shareholding
7th Dec 20153:37 pmRNSDirector/PDMR Shareholding
2nd Dec 20152:24 pmRNSResult of AGM
2nd Dec 20157:00 amRNSAGM Statement
24th Nov 20153:34 pmRNSNotice of AGM
29th Oct 20157:02 amRNSAppointment of Patrick Shanley as Chairman
29th Oct 20157:00 amRNSFinal Results
14th Oct 20157:00 amRNSNotice of Results
25th Aug 20152:40 pmRNSHolding(s) in Company
6th Aug 20154:12 pmRNSDirector/PDMR Shareholding
6th Aug 20157:00 amRNSTrading Update for 12 months ended 31 July 2015
31st Jul 20157:00 amRNSResignation of Non-Executive Director
21st Jul 201510:08 amRNSDirector/PDMR Shareholding
6th Jul 20157:00 amRNSNotification of awards under Value Creation Plan
2nd Jun 20154:52 pmRNSBlock Listing Six Monthly Return
21st Apr 201512:05 pmRNSHolding(s) in Company
21st Apr 201512:05 pmRNSDirector/PDMR Shareholding
17th Apr 20155:17 pmRNSHolding(s) in Company
17th Apr 201510:26 amRNSDirector/PDMR Shareholding
10th Apr 20159:00 amRNSBlocklisting Application
9th Apr 20157:00 amRNSNew Business Update
9th Apr 20157:00 amRNSHalf Year Financial Report
8th Apr 20151:42 pmRNSForm 8.3 - MATCHTECH GROUP
2nd Apr 20157:05 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.